ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma rises 4% on receiving court order to launch Chlorantraniliprole
Natco is the first company in India to have received its registration approval given by the Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole (CTPR) Technical 93 per cent w/w min. under Section 9(
Announcement as on 20 September 2022

Stocks to Watch: GAIL, Sona BLW, ONGC, Natco Pharma, RIL, Airtel, Vodafone
Stocks to Watch: Blackstone Inc. is seeking to raise as much as Rs 3,180 crore (0 million) through the sale of shares in Indian automotive component maker Sona Comstar
Announcement as on 18 August 2022

Hold Natco Pharma: target of Rs 735: ICICI Direct
ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 735 in its research report dated August 13, 2022.
Announcement as on 16 August 2022

Natco Pharma Q1 net profit rises multi-fold to Rs 320 cr on higher revenue
Its consolidated revenue from operations during the quarter under review stood at Rs 884.6 crore compared to Rs 410.3 crore in the same period last fiscal, it added.
Announcement as on 09 August 2022

Natco Pharma's partner Breckenridge Pharmaceutical gets FDA nod for prostate cancer treatment drug

Announcement as on 25 July 2022

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 890.94
  • 12Day Average: 907.3
  • 20Day Average: 914.62
  • 50Day Average: 918.1
  • 100Day Average: 997.86
  • 150Day Average: 964.33
  • 200Day Average: 942.83

524816 Indicators & signals

Indicator MACD (12,26,9)

904.55, 917.8, -9.99
Indicator MACD is in negative zone

Indicator ADX (14)

2.65, 20.09, 19.05
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
20 Thu Aug 2026 877.75 875.30 to 894.30 -1.05% 0.68 times
19 Wed Aug 2026 887.05 883.10 to 916.60 -1.2% 0.29 times
18 Tue Aug 2026 897.80 889.70 to 900.10 0.91% 0.36 times
17 Mon Aug 2026 889.70 870.70 to 898.85 -1.41% 1.19 times
14 Fri Aug 2026 902.40 885.75 to 962.25 -5.23% 3.67 times
13 Thu Aug 2026 952.25 917.60 to 960.40 4.07% 1.63 times
12 Wed Aug 2026 915.00 906.00 to 922.00 0.89% 0.48 times
11 Tue Aug 2026 906.90 903.55 to 929.40 -0.5% 0.76 times
10 Mon Aug 2026 911.50 905.55 to 932.00 -0.62% 0.73 times
07 Fri Aug 2026 917.15 912.00 to 921.10 0.53% 0.14 times
06 Thu Aug 2026 912.35 910.00 to 932.75 -0.58% 0.74 times
05 Wed Aug 2026 917.70 912.60 to 926.60 0.04% 3.54 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top